Search Results 281-290 of 15333 for CLL

  1. Small lymphocytic lymphoma - Care at Mayo Clinic

    Anyone have chronic lymphocytic leukemia (CLL)?. 376 Replies Wed, Sep 02, 2026. See more discussions. Related. Associated Procedures. Biological therapy for ...

  2. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  3. Hematology - Clinical trials - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  4. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  5. Pirtobrutinib (oral route) - Side effects & dosage - Mayo Clinic

    For mantle cell lymphoma, chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL):. Adults—200 milligrams (mg) once a day. Your doctor may ...

  6. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...

  7. Hematology - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  8. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. Database of All Patients with Peritoneal Surface Malignancies ...

  9. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

  10. Study To Assess The Safety And Effectiveness Of Shingrix Vaccine In Patients With Hematologic Malignancies - Mayo Clinic

    ... CLL to patients with untreated intermediate and high-risk CLL. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...